This is a phase II, open-label multicenter trial evaluating the safety, tolerability and antiviral activity of…
Category: Studies
Intrauterine device as a modern method of contraception in – Thai HIV-positive women
This is a prospective study with a follow up period of six months. The main goal…
Pharmacokinetics study of Tenofovir in HIV-infected Thai children using Tenofovir-based regimen.
This study will assess the pharmacokinetics of Tenofovir in HIV-infected Thai children using Tenofovir-based regimen.
Trial to Evaluate the Acceptability and Feasibility of “Test and Treat” and “link-to-care” to reduce HIV transmission among men having sex with men in Bangkok
This cross-sectional study will evaluate the interest and attitudes on regular voluntary HIV counseling and testing,…
Mortality and morbidity risk factors of Cytomegalovirus viremia in AIDS patients starting antiretroviral therapy in Thailand
This is a retrospective observational cohort and nested case-control study. This study will assess the possible…
Hepatitis B surface antigen levels in long term therapy of Tenofovir in HIV-HBV-coinfected patients
This is a cross section study to evaluate the role of quantitative HBsAg in predicting treatment…
An open-label study of liquid and sprinkled formulations of Efavirenz administered in combination with Didanosine and Emtricitabine in HIV-infected infants and children 3 months to 6 years of age
This study will evaluate the pharmacokinetic and efficacy of efavirenz in HIV-infected children.
A randomized, open-label, phase 2 study of subcutaneous interleukin-2 (ProleukinR) plus antiretroviral therapy (ART) versus ART alone in patients with HIV infection and CD4+ lymphocyte count greater than 350 cells/mm3
Interleukin-2 (IL-2) is an immuno-stimulatory protein, which is central to the appropriate responsiveness of the immune…
A randomized, double-blind, comparative trial to evaluate the efficacy of combination therapy with AZT 200 mg TID plus ddC 0.75 mg TID versus AZT 100 mg TID plus ddC 0.375 mg TID in an antiretroviral- naïve Thai study population
AZT given at a doses as low as 300 mg per day may be effective in…
A randomized, open-label study to explore the antiretroviral efficacy and tolerability of immediate versus deferred switching from ddI/d4T to AZT/3TC in a Thai HIV-1 infected population, pretreated with ddI/d4T
This roll-over protocal followed study HIV-NAT 002. 71 patients were re-randomized to immediate switch to AZT/3TC…
A randomized, open-label, comparative study to evaluate the efficacy and tolerability of Indinavir/low dose Ritonavir BID versus Indinavir TID as part of combination antiretroviral therapy with CombivirR (AZT+3TC) for the treatment of HIV-1 infection in an antiretroviral pretreated Thai study population
This study will be the first to evaluate a protease inhibitor as part of a triple…
A randomized, open label, study to compare the safety and biological effects of combinations od Didanosine (ddI) and Stavudine (d4T) to Didanosine monotherapy in antiretroviral naïve HIV infected subjects with CD4 cell counts of 150-350 /uL
Previous studies have shown that d4T and ddI given to antiretroviral naïve subjects with CD4 counts…
A randomized, open-label, comparative trial of AZT/3TC versus AZT/3TC/ddI in antiretroviral naïve HIV-1 infected Thai patients
An in vitro study comparing the ability of ten different three-drug combinations to prevent HIV-induced cytopathic…
